After two years of rate-driven paralysis, the freeze is over, and the next wave for the healthcare real estate market has begun. The sector established a clear market floor in the second half of 2025, with cap rates leveling around 7%. The bid-ask gap between buyers and sellers is narrowing as stakeholders realign on pricing, triggering a significant rebound in transactional activity across the sector.

 

Healthcare real estate is anchored by strong fundamentals that help it withstand broader market slowdowns, with occupancy nearing 93% across the top 100 metros and performance driven by the predictability of physician and healthcare group tenancy, according to PwC’s Medical Office Real Estate Outlook. That durability is supported by long lease terms, steady patient volumes, and limited new supply as high construction costs sideline many developers, while Future Market Insights projects the U.S. outpatient clinics market is projected to grow from about 44.3 billion in 2025 to roughly 67.4 billion by 2035, setting the stage for the next leg of the medical real estate cycle. 2026 is the turning point; but timing will determine who leads the cycle & who chases it.

 

What’s Moving the Market

Healthcare real estate operates on a distinct rhythm from the broader market, driven not by volatility but by the steady, real-time demand for patient care and accessible treatment. By 2030, one in five Americans will be over the age of 65, embedding long-term, non-cyclical demand directly into the medical real estate sector, according to the U.S. Census Bureau.

 

An aging population isn’t a trend. It’s a demographic certainty driving the need for expanded clinics, specialists, & ongoing care.

 

The shift toward distributed care is redefining where medicine happens, as healthcare undergoes a broad rebrand away from hospitalcentric delivery and toward models that prioritize convenience, flexibility, and care closer to home. Outpatient clinics, surgery centers, and specialty practices now handle procedures once limited to hospitals at operating costs 30-60% lower, making them the preferred setting for both patients and providers, according to a JAMA Network study. It’s a system built around people in their everyday life, powered by adaptable clinics rooted in the communities they serve.

 

Amid accelerating demand for outpatient and specialty clinics, the market is now running into a shortage of high-quality medical space. With construction costs still elevated, most developers remain sidelined, creating tight supply conditions just as tenant demand accelerates. That scarcity gives existing property owners real pricing power. Strategic partnerships are expected to account for only 10-15 healthcare projects breaking ground in 2026, including new behavioral health facilities in smaller markets, rural cancer treatment centers, university-affiliated hospitals, community health hubs paired with recreation amenities, and specialized units such as regional burn centers.

 

Capital that spent the last two years on the sidelines is beginning to move again, with underwriting steadying and debt costs no longer swinging week-to-week. Investors are stepping back in with clearer expectations, and their return signals renewed confidence as pricing stabilizes and debt becomes predictable. This tightening supply, paired with the sector’s resilient fundamentals, is drawing fresh interest from REITs and institutional buyers, elevating outpatient medical office buildings and intensifying competition for high-quality clinical assets as early-cycle capital begins to reemerge.

 

High-Growth Specialties to Watch

Modern care delivery is generating clear momentum in certain specialties, while others are stabilizing through consolidation or adapting to reimbursement pressures. Outpatient-oriented, cash-flow-stable, and platform-backed specialties will take the lead as the next cycle unfolds.

 

Growth Leaders

Strongest Demand, Tightest Cap Rates

• ASCs: More procedures migrating from hospitals
• Imaging: Diagnostics rising across all specialties
• Urgent Care: Convenience-based, steady
• Dialysis: Essential-care, zero elasticity

Why it matters: Early compression drivers will anchor the first wave of institutional capital.

 

High-Yield, Under-Supplied Categories

Scarcity-Driven Upside

• Behavioral Health: Payer-mix attention required, but demand surging
• Dental/Oral Surgery: DSO consolidation strengthening credit

Why it matters: Limited supply & resilient demand push rents higher and widen spreads.

 

Elective Consumer-Facing Segments

Credit Bifurcation

• Aesthetics/Med Spas: Cash-pay, high margin, platform roll-ups
• Dermatology/Plastic Surgery: Demand steady, credit tied to scale vs. boutique operations

Why it matters: Pricing hinges on operator scale & backing as platform-backed groups trade tighter.

 

Consolidation Watchlist

Shifting Credit Profiles

• Urology, Ophthalmology, Dermatology: MSO roll-ups reshaping credit consistency
• Oncology & OB/GYN: Reimbursement pressure pushing system-backed lease tenancy

Why it matters: These segments won’t set pricing, they will redefine credit strength & underwriting.

 

Valuation Patterns Defining the Sector

The differentiation of market pricing for medical assets starts with one question: Does the facility’s design directly support high-value clinical activities & operational efficiency?

Medical office buildings that are mission-critical operate in a different lane altogether, supported by renewal rates above 80% versus roughly 60% in traditional office buildings, according to the Crittenden Report and MedProperties LB. Elective operators price wider, creating a split in how investors underwrite risk.

 

Core clinical facilities, including ASCs, imaging centers, urgent care clinics, dialysis facilities, and other spaces that specialties rely on functionally, are consistently trading on narrow margins. These buildings are deeply embedded in the care-delivery process, supported by long-term leases, capital-intensive buildouts, and a high renewal probability. Providers rarely relocate, which creates stable income and predictable performance that institutional buyers prioritize. The result is a pricing environment in which essential care infrastructure commands a premium valuation and strong competition whenever it comes to market.

Elective specialties rely on discretionary spending, which creates wider pricing spreads and more volatility. Those backed by scale or private equity/MSO platforms perform far better, while standalone boutiques see higher cap rates that reflect their revenue swings.

 

The Owner-User Advantage

As institutional owners control over $537 billion in assets, according to RevistaMed’s 2025 report, the next market cycle presents a unique opportunity for private practitioners and physician-owned groups to leverage ownership and exert a new degree of influence over the sector’s evolution. Ownership transforms the practice location into an economic engine, supporting growth today and enhancing valuation tomorrow.

 

Owning the facility gives physicians the flexibility to expand services, add providers, and modernize layouts, while predictable occupancy costs provide stability to reinvest in operations and support longterm growth. As physicians near succession or retirement, a well-structured lease to the real estate entity becomes key to preserving value; renewing or adjusting that lease 12-18 months ahead of a sale— and securing successor providers or MSO support— helps solidify income and boost buyer confidence.

 

Liquidity tools like sale-leasebacks and 1031 exchanges let physicians unlock equity without disrupting care. In a sale-leaseback, the physician sells the building and stays under a new long-term lease, which buyers underwrite closely. Before pursuing a transaction, physician-owners should ensure lease terms meet market standards and align the deal with their long-term practice goals. Owners, developers, & investors should evaluate their assets before cap rate compression & institutional competition reduce margins.

 

Move Earlier, Move Smarter

Essential Market Signals & Strategies to Track over the Next 12-18 Months

 

Cap Rate Compression & Competition

Cap rates are stabilizing and will likely compress as institutional capital re-engages. As bid-ask spreads tighten, competitive pressure will rise quickly, making early positioning essential to secure strong pricing and yield.

 

Tenant Credit and Lease Stability

Monitor shifts in credit quality as consolidation accelerates in specialty sectors. Aligning with platform-backed groups or health systems will reinforce stability and mitigate reimbursementdriven volatility.

 

Supply Constraints & Development

New construction remains minimal, and the scarcity will continue to push rents upward while accelerating lease-up for high-quality outpatient assets. Any 2026-27 deliveries will benefit from this imbalance.

 

Specialty-Specific Demand Dynamics

ASCs, imaging, urgent care, and dialysis will anchor low-cap-rate demand. Behavioral health and dental/oral surgery continue to show strong rental upside due to undersupply. Elective segments will vary widely depending on operator scale and platform credit.

 

Operational and Design Execution

Rising construction costs make execution a competitive edge. Developers and owners who deliver on time and tailor spaces to clinical workflows will earn better rents and retention.

 

Financial Strategies & Owner-User Roles

Expect increased utilization of sale-leasebacks, 1031 exchanges, and joint-venture structures as physicians and private groups leverage real estate to support expansion, liquidity planning, and succession strategies in the new cycle.